Wed, February 7, 2024
Tue, February 6, 2024
Mon, February 5, 2024
Fri, February 2, 2024
Thu, February 1, 2024

Carter Gould Maintained (ABBV) at Buy with Increased Target to $185 on, Feb 5th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-185-on-feb-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $175 to $185 on, Feb 5th, 2024.

Carter has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Rajesh Kumar of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $156 on, Monday, December 18th, 2023
  • James Shin of "Deutsche Bank" Initiated at Hold and Held Target at $150 on, Thursday, November 9th, 2023


These are the ratings of the 3 analyists that currently disagree with Carter


  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024
  • Chris Shibutani of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $173 on, Monday, December 11th, 2023
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Monday, October 30th, 2023

Publication Contributing Sources